The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate‐to‐severe atopic eczema*F.M. Vermeulen, Louise A. A. Gerbens, Jochen Schmitt et al.|British Journal of Dermatology|2020Cited by 44
<scp>TRE</scp> atment of <scp>AT</scp> opic eczema ( <scp>TREAT</scp> ) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registriesF.M. Vermeulen, Lawrence F. Eichenfield, Andrea Manca et al.|British Journal of Dermatology|2019Cited by 38
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczemaAngela L. Bosma, Carsten Flohr, Phyllis I. Spuls et al.|British Journal of Dermatology|2019Cited by 25
On which evidence can we rely when prescribing off-label methotrexate in dermatological practice? – a systematic review with GRADE approachAstrid M. van Huizen, Phyllis I. Spuls, F.M. Vermeulen et al.|Journal of Dermatological Treatment|2021Cited by 6
On which evidence can we rely when prescribing off-label methotrexate in dermatological practice? – a systematic review with GRADE approachAstrid M. van Huizen, Phyllis I. Spuls, F.M. Vermeulen et al.|Figshare|2021Cited by 0